Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsFresenius kabi

    Fresenius Kabi

    Jump to

    • Claris settles litigation with Fresenius Kabi on 'Diprivan'

      In December 2014, Fresenius Kabi had filed a suit against Claris Lifesciences to block commercialisation of its abbreviated new drug application (ANDA) for Propofol, used to induce or maintain anesthesia during surgeries.

    • Fresenius Kabi standalone Dec '13 sales at Rs 84.66 crore

      Fresenius Kabi Oncology has reported a standalone sales turnover of Rs 84.66 crore and a net loss of Rs 63.63 crore for the quarter ended Dec '13

    • Stocks in news: Infosys, Fresenius Kabi, Bayer Crop, BoB

      Infosys | Hatsun Agro | Fresenius Kabi | Central Bank | Union Bank | SBI | GMDC | Suzlon Energy | Tata Teleservices | Oberoi Realty | Subex | Aegis Logistics | Sanofi | EIH | Jagran Prakashan | Balaji Telefilms | Bayer Cropscience | Dr Reddys Labs | Jubilant Foodworks | Titan Industries and Bank of Baroda are stocks, which are in the news today.

    • Fresenius Kabi standalone Sep '13 sales at Rs 96.15 crore

      Fresenius Kabi Oncology has reported a standalone sales turnover of Rs 96.15 crore and a net loss of Rs 44.79 crore for the quarter ended Sep '13

    • Stocks in news: L&T, Dhanlaxmi Bank, UltraTech, Fresenius

      L&T | ONGC | Coal India | Natco Pharma | Fresenius Kabi | IPCA Labs | Unitech | Dhanlaxmi Bank | UltraTech Cement | Petronet LNG | CRISIL | Unichem Labs and Supreme Petrochem are stocks, which are in the news today.

    • Stocks in news: India Infoline, Ranbaxy, IOC, REC, L&T Fin

      Fresenius Kabi | ARSS Infrastructure | Bombay Rayon | Uttam Galva | India Infoline | L&T Finance Holdings | Man Industries | Jet Airways | HPCL | HCL Technologies | Power Grid | Jaiprakash Associates | Ranbaxy Labs | IOC | REC | Bosch and SKS Microfinance are stocks, which are in the news today.

    • Govt clears 17 FDI proposals worth Rs 993 cr

      The proposal of Jet Airways India, amounting to Rs 2,057.66 crore, has been recommended for consideration of the Cabinet Committee on Economic Affairs. Jet Airways proposes to sell a 24 per cent stake to Abu Dhabi-based Etihad Airways.

    • Fresenius Kabi standalone Jun '13 sales at Rs 126.87 crore

      Fresenius Kabi Oncology has reported a sales standalone turnover of Rs 126.87 crore and a net profit of Rs 4.80 crore for the quarter ended Jun '13

    • Fresenius Kabi tanks 19% ahead of SAT hearing on delisting

      At the NSE, the stock tumbled 18.64 per cent to Rs 119.10. Fresenius Kabi Oncology has again approached SAT against Sebi which recently gave a conditional nod to the company to delist from the Indian stock market.

    • Stocks in news: Idea, Bank of Baroda, Wockhardt, IOC, IRB

      Gati | Religare Enterprises | Jagran Prakashan | JM Financial | Cholamandalam Finance | Jubilant Industries | Strides Arcolabs | IRB Infrastructure | Geodesic | Wockhardt | Fresenius Kabi | Neyveli Lignite | IOC | Financial Technologies and MCX are stocks, which are in the news today.

    • Fresenius moves SAT against Sebi's delisting order

      Fresenius Kabi Oncology has again approached Securities Appellate Tribunal (SAT) against Sebi which recently gave a conditional nod to the company to delist from Indian stock market.

    • Stocks in news: Jet Airways, Zuari Agro, Sesa Goa, Prestige

      Jet Airways | Zuari Agro | Geometric | Prestige Estates | Jaypee Infratech | Merck | City Union Bank | Sesa Goa | Dr Reddys Labs | Fresenius Kabi | Man Industries | Jindal Steel and Sterlite Industries are stocks, which are in the news today.

    • USFDA cracks down on Indian made 'natural' diabetes drugs

      US Food and drug authority has initiated action against 15 companies, including a Gujarat based drug maker, for the supply of 'natural' drugs for the cure of diabetes.

    • Bull's Eye: Sell Titan, Punj Lloyd; buy Mindtree, Tech Mah

      Prakash Diwan of Altamount Capital Management recommended buying GMR Infrastructure with a target price of Rs 17.25 and Mindtree with a target price of Rs 991.

    • SP Tulsian's multibaggers: Fresenius Kabi, ING Vysya Bank

      SP Tulsian of sptulsian.com expects Fresenius Kabi shares to breach Rs 200 if serious delisting move is initiated by the promoters. He expects ING Vysya Bank to post around 13-15 percent growth on the bottom-line annually.

    • Bull's Eye: Buy YES Bank, M&M Financial, Jet Airways, Eros

      Sharmila Joshi of Peerless Securities advised buying Shriram Transport Finance with a target price of Rs 675 and YES Bank with a target price of Rs 433.

    • Stocks in news: ING Vysya Bank, HOEC, Fresenius Kabi, Jet

      ING Vysya Bank | HOEC | L&T Finance Holding | Best Eastern | United Spirits | Indiabulls Housing Finance | Vascon Engineering | Bayer Cropscience | JSPL | Jet Airways and Fresenius Kabi are stocks, which are in the news today.

    • Stocks in news: Reliance Communications, DLF, Bharti

      Reliance Communications | Gujarat Fluorochemicals | Mawana Sugars | Ashok Leyland | Aptech | DLF | Geojit BNP | Bharti Airtel | YES Bank | Fresenius Kabi | Wockhardt | Bajaj Hindusthan | Gillette India and Lupin are stocks, which are in the news today.

    • Frensensius Kabi clears SAT hurdle, gets interim relief

      Fresenius Kabi's delisting drive got a major boost from the Securities Appellate Tribunal (SAT) on Monday.

    • Stocks in news: Moser Baer, HCL Tech, Ranbaxy, Neyveli

      Moser Baer | Zydus Wellness | HCL Technologies | Ranbaxy Labs | Tata Communications | Polaris | TCS | Infosys and Neyveli Lignite are stocks, which are in the news today.

    • The Curious Case Of Fresenius Kabi!

      Last year, in May, the foreign parent of Fresenius Kabi, an Indian oncology drugs company, announced its intention to sell up to 15% promoter stake and reduce its shareholding to 75% via one or more OFS.

    • Sell Fresenius Kabi advises Sharmila Joshi

      Sharmila Joshi, Head of Equity at Peerless Securities advised selling Fresenius Kabi because there could be some uncertainty over delisting of company.

    • Buy Fresenius Kabi, Videocon Ind, Karnataka Bank: Tulsian

      In CNBC-TV18's popular show Bull's Eye, SP Tulsian of sptulsian.com shares trading strategy of the day.

    • Parenteral Drugs sells its arm's Goa unit, stock falls 9%

      Parenteral Drugs (India) dropped nearly 18 percent from day's high on Friday after the company sold its subsidiary's Goa unit to Fresenius Kabi.

    • Will use sale proceeds to diversify operations: Parenteral

      Parenteral Drugs (India) sold their IV Fluid manufacturing unit at Goa to Fersenius Kabi India (P) Limited for Rs 200 crore.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347